drugset / Trial / NCT04669561

The Chronology of Lifitegrast Effect on Anterior Surface Rehabilitation (CLEAR) Study

NCT04669561

Phase 4 Completed 100 enrolled Research Insight LLC
NaSingle-groupOpen-labelTreatment

Summary

In patients with dry eye, defined as corneal staining and a reduced tear breakup time, lifitegrast will improve higher order aberrations, ocular scatter index, corneal staining, and TBUT as soon as 1 week after initiating treatment.

Timeline

Start
2021-03-17
Primary completion
2021-08-31
Completion
2021-10-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Lifitegrast Unknown 5 % Other

Indications